OSU 03012 is an orally available, targeted anti-cancer agent that has been shown in pre-clinical studies to inhibit PDK-1, a protein in the PI3K/Akt pathway that is involved in the growth and proliferation of cells, including cancer cells. OSU 03012 may also cause cell death through the induction of stress in the endoplasmic reticulum.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | PDK-1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye